ArticleJournal of fluorescence2024
Biosynthesis, Spectroscopic, and Antibacterial Investigations of Silver Nanoparticles.
Article in Journal of fluorescence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 26 citations in OpenAlex.
- Exploring the Interaction of Diester-Bonded Cationic Gemini Surfactant Functionalized Silver Nanoparticles with PSA: Analysis Involving Spectroscopic and Tensiometric Approaches.Journal of fluorescence · 2026Article
- Multicolour Luminescence from Undoped ZnO Nanoparticles: An Exciting Outcome of Controlling the Annealing Atmosphere in a Facile Manner.Journal of fluorescence · 2025Article
- Performance of Nanotechnology in Cementitious Materials: Synthesis and Application.Materials (Basel, Switzerland) · 2025Review
- Article
- The emerging role of extracellular vesicles in diabetes and complications: mechanistic insights and translational prospects.Frontiers in endocrinology · 2025Review
- Article
- Green synthesis of silver nanoparticles by sweet cherry and its application against cherry spot disease.Heliyon · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Silver nanoparticles can be produced by an array of procedures, such as chemical, physical, and biological processes. The process of biosynthesis is more economical and significantly more environmentally friendly. We describe an environmentally compatible method (biosynthesis) of producing silver nanoparticles (Ag: NPs) with the capping component Artocarpus heterophyllus in this research work. Powder-X-ray crystallography (P-XRD), Fourier Transform Infrared (FT-IR), UV-visible (UV-Vis), Photoluminescence (PL), Field emission scanning electron microscopy (FE-SEM), and an antimicrobial test were all used to examine the synthesized samples. The P-XRD analysis revealed that the produced NPs have an FCC form with a typical particle size of 23 nm. FT-IR spectra further demonstrate the availability of the functional groups in the synthesized nanoparticles. The absorbance and transmittance spectra of the UV-Vis study have shown substantial transparency and less absorbance of the Ag: NPs in the entire visible region. The bandgap of the Ag: NPs was found to be 3.25 eV using the Tauc relation. In the PL study, an emission peak at 472 nm was found, suggesting the fluorescence emission of Ag: NPs. The FE-SEM micrographs provide confirmation of the surface-wide aggregate of nanostructural homogeneities. The FE-SEM micrographs illustrate that Ag: NPs are homogeneous aggregates of very small spheres. Variations in particle size and surface area-to-volume ratios of synthesized NPs have been proven to be responsible for the antibacterial activities. According to the antibacterial study, Ag: NPs restrain the development of both normal and harmful bacteria and so have the potential to be utilized for coating surgical equipment for aseptic operators in the healthcare industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.